[HTML][HTML] Epidemiology of environmental exposure and malignant mesothelioma

B Liu, M van Gerwen, S Bonassi, E Taioli - Journal of Thoracic Oncology, 2017 - Elsevier
Although the association between exposure to asbestos and malignant mesothelioma
(particularly malignant pleural mesothelioma) has been well established, the health impact …

Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum-and histological-type dependent

RM Jagirdar, E Apostolidou… - … of Physiology-Lung …, 2016 - journals.physiology.org
Malignant pleural mesothelioma (MPM) is an aggressive cancer. MPM cells express
aquaporin-1 (AQP1) that in other cancers has been shown to participate in the tumor …

Risk factors of mortality from all asbestos‐related diseases: a competing risk analysis

R Abós-Herràndiz, T Rodriguez-Blanco… - Canadian …, 2017 - Wiley Online Library
Background. The mortality from all malignant and nonmalignant asbestos‐related diseases
remains unknown. The authors assessed the incidence and risk factors for all asbestos …

[PDF][PDF] Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in Turkey

M Kucukoner, MA Kaplan, A Inal, Z Urakci, O Abakay… - J BUON, 2014 - researchgate.net
Purpose: To compare treatment modalities and investigate potential prognostic factors for
survival in patients with malignant pleural mesothelioma (MPM). Methods: The present study …

Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups

G Utkan, Y Ürün, A KAYI CANGIR… - Asian Pacific Journal …, 2013 - avesis.ankara.edu.tr
Background: Malignant mesothelioma (MM) is an aggressive tumor of mesothelial surfaces.
Previous studies have observed an association between ABO blood groups and risk of …

The clinicopathological characteristics with long-term outcomes in malignant mesothelioma

M Dogan, G Utkan, C Hocazade, D Uncu, S Toptas… - Medical Oncology, 2014 - Springer
Malignant mesothelioma (MM) is a neoplasm which originates from serous membranes. It is
relatively more common in Turkey. Ninety-nine patients between 2002–2009 were …

[HTML][HTML] The role of immunohistochemistry studies in distinguishing malignant mesothelioma from metastatic lung carcinoma in malignant pleural effusion

M Halimi, S BeheshtiRouy, D Salehi… - Iranian Journal of …, 2019 - ncbi.nlm.nih.gov
Results: In patients with adenocarcinoma CK7 in 100% of patients (13 patients), TTF1 in
61.5% of patients (8 patients) and CEA in 53.8% of patients (7 patients) were positive, but …

Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma

A Szulkin, T Szatmári, A Hjerpe, K Dobra - Pleura and Peritoneum, 2019 - degruyter.com
Cell based chemosensitivity and resistance testing is an attractive approach that offers
functional measurement of drug response ex vivo with the ultimate goal to guide the choice …

Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis

RA Herràndiz, TR Blanco, IG Allas… - Canadian Respiratory … - digitalcommons.usf.edu
Background. The mortality from all malignant and nonmalignant asbestos-related diseases
remains unknown. The authors assessed the incidence and risk factors for all asbestos …

[PDF][PDF] Potential Novel Prognostic Factors in Malign Mesothelioma: Systemic Inflammatory Indices (SII) & Albumin-to-Globulin Ratio (AGR)

S Karakaya, İ Karadağ, M Dogan… - Acta Oncologica …, 2021 - jag.journalagent.com
Introduction: Malignant mesothelioma (MM) is rare with poor prognosis and often diagnosed
at advanced stage. Systemic inflammatory indices (SII) may have prognostic value in cancer …